Shervin Tabrizi, MD
Radiation Oncology Physician · Philadelphia, PA
Shervin Tabrizi, MD is a radiation oncology physician with a practice address in Philadelphia, Pennsylvania, and NPI 1104354109, issued on Jun 2, 2017. Check the license (Pennsylvania MD489450, as entered in NPPES) on the Pennsylvania Department of State (PALS); the Medicare figures below come from public CMS files.
- Name
- Shervin Tabrizi
- Credential
- MD
- Primary taxonomy
- Radiation Oncology Physician 2085R0001X
- License number
- MD489450 PA
Self-reported in NPPES; status is on the state search - Practice location
- 3400 Spruce Street, Philadelphia, PA 19104
- Phone
- (215) 662-2428
- Enumerated
- Jun 2, 2017
- Record last updated
- Oct 2, 2025
- Fax
- (215) 349-5923
- Medicare enrollment
- Enrolled (PECOS I20250812001324); accepts Medicare assignment
- Entity
- Type 1 · individual
Also registered at 3400 Spruce Street
A shared address usually means a shared clinic or building; it does not show who employs whom.
- Stephanie Abbuhl, MDEmergency Medicine Physician1649215195
- Shahrzad Abdollahi, M.D.Rheumatology Physician1518494178
- Sarah Abdulla, MDVascular & Interventional Radiology Physician1427342336
- Alice Abernathy, MDObstetrics & Gynecology Physician1740711498
- Mariam Aboian, M.D., PH.D.Diagnostic Radiology Physician1356669386
- Samir Abu Gazala, M.D.Surgery Physician1750708251
Verify Shervin Tabrizi in five checks
- 1IdentityNPI record in CMS NPPESNPI lookupConfirmed in NPPES
- 2LicenseActive license and public ordersPennsylvania Department of State (PALS)
Search for license MD489450Check the board - 3Other statesLicenses and actions elsewhereDocInfo (FSMB)Not checked
- 4ExclusionsMedicare and Medicaid bansHHS-OIG exclusion listNot checked
- 5CertificationBoard certificationABMS AOA NCCPA AANPNot checked
Bills Medicare through 2 group practices
- Massachusetts General Physicians Organization IncBoston, MA
- University OF Penn - Medical GroupPhiladelphia, PA
Source: CMS Doctors and Clinicians National Downloadable File (the group practices a clinician bills Medicare through) (data.cms.gov).
Radiation Oncology Physician providers in Pennsylvania
There are 383 radiation oncology physician records in Pennsylvania.
Other radiation oncology physician records in Pennsylvania
- Stephen Abel, DOClarion, PA1033642319
- Manuj Agarwal, MDPhiladelphia, PA1316262363
- Peter Ahn, M.D.Philadelphia, PA1710117106
- Ayesha Ali, MDLancaster, PA1538663851
- Fiori AliteLewisburg, PA1811289127
- Michelle Alonso-Basanta, MDPhiladelphia, PA1831393800
- Antonio Ambrad, M.D.Pittsburgh, PA1205837143
- Penny Anderson, M.D.Philadelphia, PA1811969868
- David Andolino, MDEaston, PA1477715407
- Charles Andrews, MDAllentown, PA1427031657
Common questions
What is Shervin Tabrizi, MD's NPI number?
Shervin Tabrizi, MD's National Provider Identifier (NPI) is 1104354109, issued on Jun 2, 2017. An NPI identifies a provider in billing; it is not a license.
Where is Shervin Tabrizi, MD located?
The NPPES record lists a practice address at 3400 Spruce Street, Philadelphia, PA, 19104. Phone: (215) 662-2428. Providers update this record themselves, so call before visiting.
How can I verify Shervin Tabrizi, MD's license?
NPPES lists Pennsylvania license number MD489450, as entered by the provider. Search the Pennsylvania Department of State (PALS) at https://www.pals.pa.gov/. The NPPES record confirms identity only; the state search shows license status, expiration and public orders.
Source: CMS National Plan and Provider Enumeration System (NPPES), file of Aug 9, 2026 (NPPES files on CMS.gov); NUCC Health Care Provider Taxonomy. Medicare files from data.cms.gov. An NPI identifies who bills; it is not a license.
Figures on PlainDoctor are read from the federal files each page names (CMS NPPES, Medicare Part D, MIPS, Open Payments; the HHS-OIG exclusion list only as counts) and from Census population estimates, with the file date shown beside them. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of Aug 9, 2026.